Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALKEM LABORATORIES vs STERLING BIOTECH - Comparison Results

STERLING BIOTECH 
   Change

Sterling Biotech primarily produces and distributes pharmaceutical grade gelatine globally. The company currently has a 7.5% share of the global market for pharmaceutical and nutraceutical gelatines. It has more than 70% market share in India. Sterli... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALKEM LABORATORIES STERLING BIOTECH ALKEM LABORATORIES/
STERLING BIOTECH
 
P/E (TTM) x 25.0 -0.4 - View Chart
P/BV x 6.0 0.0 42,261.5% View Chart
Dividend Yield % 0.8 0.0 -  

Financials

 ALKEM LABORATORIES   STERLING BIOTECH
EQUITY SHARE DATA
    ALKEM LABORATORIES
Mar-20
STERLING BIOTECH
Dec-13
ALKEM LABORATORIES/
STERLING BIOTECH
5-Yr Chart
Click to enlarge
High Rs2,72011 25,904.8%   
Low Rs1,6603 48,833.8%   
Sales per share (Unadj.) Rs697.926.8 2,603.3%  
Earnings per share (Unadj.) Rs96.1-15.0 -642.6%  
Cash flow per share (Unadj.) Rs117.3-5.5 -2,146.5%  
Dividends per share (Unadj.) Rs25.000-  
Dividend yield (eoy) %1.10-  
Book value per share (Unadj.) Rs515.254.9 938.8%  
Shares outstanding (eoy) m119.57267.87 44.6%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.10.3 1,210.5%   
Avg P/E ratio x22.8-0.5 -4,903.7%  
P/CF ratio (eoy) x18.7-1.3 -1,468.1%  
Price / Book Value ratio x4.30.1 3,356.7%  
Dividend payout %26.00-   
Avg Mkt Cap Rs m261,8791,862 14,066.7%   
No. of employees `00014.31.4 1,058.4%   
Total wages/salary Rs m15,055547 2,753.3%   
Avg. sales/employee Rs Th5,822.65,303.3 109.8%   
Avg. wages/employee Rs Th1,050.5403.8 260.1%   
Avg. net profit/employee Rs Th802.0-2,959.0 -27.1%   
INCOME DATA
Net Sales Rs m83,4447,181 1,162.1%  
Other income Rs m1,04243 2,446.5%   
Total revenues Rs m84,4867,223 1,169.6%   
Gross profit Rs m14,734947 1,556.0%  
Depreciation Rs m2,5282,543 99.4%   
Interest Rs m6514,377 14.9%   
Profit before tax Rs m12,598-5,931 -212.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,105-1,924 -57.4%   
Profit after tax Rs m11,493-4,007 -286.9%  
Gross profit margin %17.713.2 133.9%  
Effective tax rate %8.832.4 27.0%   
Net profit margin %13.8-55.8 -24.7%  
BALANCE SHEET DATA
Current assets Rs m54,96014,335 383.4%   
Current liabilities Rs m32,43349,809 65.1%   
Net working cap to sales %27.0-494.0 -5.5%  
Current ratio x1.70.3 588.8%  
Inventory Days Days80403 19.7%  
Debtors Days Days72171 42.3%  
Net fixed assets Rs m32,71055,432 59.0%   
Share capital Rs m239268 89.2%   
"Free" reserves Rs m61,36813,935 440.4%   
Net worth Rs m61,60714,701 419.1%   
Long term debt Rs m1,5929,478 16.8%   
Total assets Rs m99,43373,988 134.4%  
Interest coverage x20.4-0.4 -5,736.8%   
Debt to equity ratio x00.6 4.0%  
Sales to assets ratio x0.80.1 864.7%   
Return on assets %12.20.5 2,438.2%  
Return on equity %18.7-27.3 -68.5%  
Return on capital %21.0-6.4 -326.2%  
Exports to sales %19.125.9 73.6%   
Imports to sales %3.00.2 1,751.4%   
Exports (fob) Rs m15,9171,860 855.9%   
Imports (cif) Rs m2,48312 20,351.6%   
Fx inflow Rs m16,0611,860 863.6%   
Fx outflow Rs m2,48325 9,975.5%   
Net fx Rs m13,5781,835 740.0%   
CASH FLOW
From Operations Rs m5,8511,719 340.4%  
From Investments Rs m-7,414-3,148 235.5%  
From Financial Activity Rs m7921,426 55.5%  
Net Cashflow Rs m-731-3 21,502.9%  

Share Holding

Indian Promoters % 66.9 33.9 197.3%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 33.1 0.0 -  
FIIs % 0.0 9.9 -  
ADR/GDR % 0.0 16.9 -  
Free float % 0.0 39.3 -  
Shareholders   68,381 21,482 318.3%  
Pledged promoter(s) holding % 0.0 55.9 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALKEM LABORATORIES With:   ALEMBIC  SUN PHARMA  PIRAMAL ENTERPRISES  FDC  NEULAND LABS  

Compare ALKEM LABORATORIES With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Momentum Moves: The Week Gone By(Momentum Moves)

Nifty and Sensex ended the week gaining 0.60% and 0.52% respectively. Bulls started the week roaring but since Wednesday, the momentum seemed to be tiring.

Related Views on News

Most Popular

My Top Stock Recommendation for 2021 and Beyond(Profit Hunter)

Jan 5, 2021

My new guide will show you the huge potential in future proof businesses.

'Essential' Smallcap Stock Recommendations(Profit Hunter)

Jan 8, 2021

The smallcap rally has enough steam left in it. If you haven't joined yet, it is still not too late.

Is Nifty Forming a Top(Fast Profits Daily)

Jan 8, 2021

The charts are telling the bulls to be cautious.

Why Gold Hit Lower Circuit(Fast Profits Daily)

Jan 11, 2021

Were you shocked that bullion prices hit lower circuits on Friday on the MCX? Find out why it happened...

Five Wishes and a Will(The Honest Truth)

Jan 4, 2021

Ajit Dayal on the investing strategy for 2021 and beyond.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

ALKEM LABORATORIES SHARE PRICE


Jan 15, 2021 (Close)

TRACK ALKEM LABORATORIES

  • Track your investment in ALKEM LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALKEM LABORATORIES

ALKEM LABORATORIES 8-QTR ANALYSIS

COMPARE ALKEM LABORATORIES WITH

MARKET STATS